Ultima Genomics announces that it will provide three trillion DNA sequencing reads free of charge to researchers across the ...

Activist investor Keith Meister will join the board of gene-sequencing maker Illumina , and current board member Scott Gottlieb will become chairman, the Wall Street Journal reported on Tuesday, ...

Beijing banned imports of Illumina’s gene-sequencing machines in response to U.S. tariffs.

Illumina is an applied genomics technology ... effective and precise the therapies will be for patients. The big promise of sequencing technology is high accuracy power and operating efficiencies ...

Illumina lowered its annual financial forecast and says it plans to cut about $100 million in costs after China banned imports of its gene sequencers last week. The San Diego maker of gene ...

Illumina expects to reach a growth rate in its revenues of 6%-9% CAGR by 2027. See why I think ILMN stock is an appealing investment opportunity.

Illumina Inc. (NASDAQ:ILMN), a leading provider of next-generation sequencing (NGS) technology with annual revenue of $4.37 billion, finds itself at a critical juncture as it navigates a shifting ...

By collaborating with core facilities, researchers new to NGS gain training and support while confidently tackling big questions and making significant discoveries. Download the new Introduction to ...

While it used to be that the sequencing portion was a big chunk of the whole workflow’s costs, nowadays it’s in line with the ...

Struggling gene-sequencing machine and chemical company Illumina (ILMN) has fallen further into the hands of activist investors. Keith ...

Keith Meister, Corvex Management’s chief investment officer, will join Illumina’s board starting March 28. He’s no stranger ...

Activist investor Keith Meister will join the board of directors of troubled gene-sequencing maker Illumina, and current board member Scott Gottlieb will become chairman, according to people familiar ...